Arthur Torres plans CDNA stock sale under Form 144

Arthur Torres has filed a notice for the proposed sale of up to 4,200 shares of CDNA common stock through Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

Arthur Torres has filed a notice for the proposed sale of up to 4,200 shares of CDNA common stock through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares, with an aggregate market value of $200,475.24 as of 08/10/2026, were acquired as restricted stock from the issuer on 06/10/2026. Over the prior three months, Torres reported sales of 6,484 shares for $128,977.78 on 05/15/2026 and 4,086 shares for $85,697.72 on 05/14/2026.

Key Figures

Shares proposed for sale: 4,200 shares Aggregate market value: $200,475.24 Prior sale 1: 6,484 shares for $128,977.78 +2 more

5 metrics

Shares proposed for sale 4,200 shares Common stock covered by the notice through Morgan Stanley Smith Barney LLC

Aggregate market value $200,475.24 Value of 4,200 shares as of 08/10/2026

Prior sale 1 6,484 shares for $128,977.78 Common stock sale on 05/15/2026

Prior sale 2 4,086 shares for $85,697.72 Common stock sale on 05/14/2026

Acquisition date of shares 06/10/2026 Date restricted stock was acquired from issuer

Key Terms

Form 144, Restricted Stock, Securities To Be Sold, Executive Financial Services

4 terms

Form 144 regulatory

"Arthur Torres has filed a notice for the proposed sale under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"The shares were acquired as restricted stock from the issuer on 06/10/2026"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 06/10/2026 | Restricted Stock"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What CDNA shares does Arthur Torres plan to sell under Form 144?

Arthur Torres filed to sell up to 4,200 shares of CDNA common stock. The planned sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate market value of $200,475.24 as of 08/10/2026.

At what value are Arthur Torres’s planned CDNA share sales recorded?

The planned sale of 4,200 CDNA shares is recorded at an aggregate market value of $200,475.24. This figure reflects the value as of 08/10/2026 in the Form 144 notice.

How and when did Arthur Torres acquire the CDNA shares to be sold?

The 4,200 CDNA shares covered by the notice were acquired as restricted stock from the issuer. The acquisition date listed is 06/10/2026, and the security type is identified as common stock.

What CDNA stock has Arthur Torres sold in the last 3 months before this notice?

Over the prior three months, Arthur Torres reported selling 6,484 shares of CDNA for $128,977.78 on 05/15/2026 and 4,086 shares for $85,697.72 on 05/14/2026, both in common stock.

Which broker is handling Arthur Torres’s planned CDNA stock sale?

The planned sale of 4,200 CDNA shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 04:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001251737
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAREDX, INC.
SEC File Number	001-36536
Address of Issuer	8000 Marina Boulevard, Brisbane CALIFORNIA 94005
Phone	415-287-2300
Name of Person for Whose Account the Securities are To Be Sold	ARTHUR TORRES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4200	200475.24	51734223	08/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/10/2026	Restricted Stock	Issuer			4200	06/10/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ARTHUR TORRES 8000 Marina Boulevard, Brisbane CA 94005	Common	05/15/2026	6484	128977.78
ARTHUR TORRES 8000 Marina Boulevard, Brisbane CA 94005	Common	05/14/2026	4086	85697.72

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Arthur Torres
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)